AFTEREFFECT OF High Vs Low Dosages Of Chloroquine Diphosphate As Adjunctive Therapy For Patients Hospitalized With Severe Acute Respiratory Symptoms Coronavirus 2

While the FDA awarded emergency use authorization for both chloroquine phosphate and hydroxychloroquine sulfate products for COVID-19 in March, on June 15, it revoked the authorization, citing ineffectiveness and serious part effects. For every chloroquine routine and each weight category considered, we simulated 1000 pharmacokinetic profiles. The simulation was run from the time of the… Continue reading AFTEREFFECT OF High Vs Low Dosages Of Chloroquine Diphosphate As Adjunctive Therapy For Patients Hospitalized With Severe Acute Respiratory Symptoms Coronavirus 2